| FAPTX | RBDTX | FAPTX / RBDTX | |
| Total Expense Ratio | 0.67 | 1.40 | 48% |
| Annual Report Gross Expense Ratio | 0.67 | 1.40 | 48% |
| Fund Existence | 12 years | 19 years | - |
| Gain YTD | 14.238 | 13.433 | 106% |
| Front Load | N/A | N/A | - |
| Min. Initial Investment | 250 | 250 | 100% |
| Min. Initial Investment IRA | N/A | N/A | - |
| Net Assets | 32.3B | 32.3B | 100% |
| Annual Yield % from dividends | 2.23 | 1.59 | 141% |
| Returns for 1 year | 9.23 | 8.39 | 110% |
| Returns for 3 years | 28.33 | 25.95 | 109% |
| Returns for 5 years | 18.02 | 14.51 | 124% |
| Returns for 10 years | 54.53 | 48.78 | 112% |
| 1 Day | |||
|---|---|---|---|
| ETFs / NAME | Price $ | Chg $ | Chg % |
| SGDJ | 89.05 | 2.83 | +3.28% |
| Sprott Junior Gold Miners ETF | |||
| YGLD | 43.69 | 0.62 | +1.44% |
| Simplify Gold Strategy PLUS Income ETF | |||
| RQI | 11.39 | -0.01 | -0.09% |
| COHEN & STEERS QUALITY Income REALTY FUND | |||
| KEMX | 37.43 | -0.17 | -0.44% |
| KraneShares MSCI Em Mkts ex CHN ETF | |||
| BIS | 9.50 | -0.15 | -1.53% |
| ProShares UltraShort Nasdaq Biotech | |||